Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PassItOn: Convalescent Plasma for COVID-19
NCT04362176Phase 3Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2020
- Primary completion
- Jul 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Vanderbilt University Medical Center. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04362176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362176.